ALPMF
Price:
$9.68
Market Cap:
$2.68T
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a beta-3 adrenergic receptor agonist for the treatment of urgency, urinary frequency, and urge urinary incontinence; Evrenzo, an oral treatment for anemia associated with chronic kidney disease; and Prograf and Advagraf/Graceptor/ASTAGRAF, which are im...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2010-04-26
Stock Exchange
PNK
Ticker
ALPMF
According to Astellas Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.37T. This represents a change of -11.10% compared to the average of 3.79T of the last 4 quarters.
The mean historical Enterprise Value of Astellas Pharma Inc. over the last ten years is 3.24T. The current 3.37T Enterprise Value has changed 10.30% with respect to the historical average. Over the past ten years (40 quarters), ALPMF's Enterprise Value was at its highest in in the September 2023 quarter at 4.29T. The Enterprise Value was at its lowest in in the December 2018 quarter at 2.41T.
Average
3.24T
Median
3.21T
Minimum
2.79T
Maximum
4.04T
Discovering the peaks and valleys of Astellas Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.76%
Maximum Annual Enterprise Value = 4.04T
Minimum Annual Increase = -29.50%
Minimum Annual Enterprise Value = 2.79T
Year | Enterprise Value | Change |
---|---|---|
2024 | 3.72T | 13.63% |
2023 | 3.27T | -3.31% |
2022 | 3.38T | 7.86% |
2021 | 3.14T | -5.13% |
2020 | 3.31T | 9.14% |
2019 | 3.03T | 4.31% |
2018 | 2.91T | 4.25% |
2017 | 2.79T | -2.04% |
2016 | 2.85T | -29.50% |
2015 | 4.04T | 73.76% |
The current Enterprise Value of Astellas Pharma Inc. (ALPMF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.46T
5-year avg
3.36T
10-year avg
3.24T
Astellas Pharma Inc.’s Enterprise Value is greater than Bristol-Myers Squibb Company PFD CONV 2 (183.67B), less than Otsuka Holdings Co., Ltd. (4.61T), less than Chugai Pharmaceutical Co., Ltd. (0), less than AstraZeneca PLC (9.94T), greater than Astellas Pharma Inc. (234.40B), less than Bayer Aktiengesellschaft (3.48T), greater than Daiichi Sankyo Company, Limited (14.80B), less than Grifols, S.A. (7.75T), greater than Roche Holding AG (6.05B), greater than Horizon Therapeutics Public Limited Company (234.35B), greater than Novartis AG (210.00M), greater than Roche Holding AG (222.02B), greater than null (238.14B),
Company | Enterprise Value | Market cap |
---|---|---|
183.67B | $140.16B | |
4.61T | $31.34B | |
0 | $66.78B | |
9.94T | $207.63B | |
234.40B | $18.04B | |
3.48T | $20.24B | |
14.80B | $54.65B | |
7.75T | $6.98B | |
6.05B | $227.29B | |
234.35B | $0 | |
210.00M | $203.47B | |
222.02B | $231.54B | |
238.14B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Astellas Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Astellas Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Astellas Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Astellas Pharma Inc. (ALPMF)?
What is the 3-year average Enterprise Value for Astellas Pharma Inc. (ALPMF)?
What is the 5-year average Enterprise Value for Astellas Pharma Inc. (ALPMF)?
How does the current Enterprise Value for Astellas Pharma Inc. (ALPMF) compare to its historical average?